Alpha-synuclein propagation: New insights from animal models-Reference-Cited by-同舟云学术

Alpha-synuclein propagation: New insights from animal models

Published:2015-09-08 Issue:2 Volume:31 Page:161-168
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Dehay Benjamin¹²,Vila Miquel³⁴⁵,Bezard Erwan¹²,Brundin Patrik⁶,Kordower Jeffrey H.⁷

Affiliation:

1. Université de Bordeaux, Institut des Maladies Neurodégénératives; UMR 5293 Bordeaux France

2. CNRS, Institut des Maladies Neurodégénératives; UMR 5293 Bordeaux France

3. Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute; Centro Investigación Biomédica en Red Enfermedades Neurodegenerativas; Barcelona Spain

4. Department of Biochemistry and Molecular Biology; Autonomous University of Barcelona; Bellaterra Barcelona Spain

5. Catalan Institution for Research and Advanced Studies; Barcelona Spain

6. Laboratory for Translational Parkinson's Disease Research; Center for Neurodegenerative Science, Van Andel Research Institute; Grand Rapids Michigan USA

7. Department of Neurological Sciences, The Graduate College; Rush University; Chicago Illinois USA

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference66 articles.

1. Targeting α-synuclein for treating Parkinson's disease: mechanistic and therapeutic considerations;Dehay;Lancet Neurol,2015

2. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease;Polymeropoulos;Science,1997

3. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease;Chartier-Harlin;Lancet,2004

4. alpha-Synuclein locus triplication causes Parkinson's disease;Singleton;Science,2003

5. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease;Kruger;Nat Genet,1998

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Viewpoint on Rat Models of Locomotion Abnormalities and Neurobiological Indicators in Parkinson's Disease;CNS & Neurological Disorders - Drug Targets;2024-04

2. The Expression and Functionality of CB1R-NMDAR Complexes Are Decreased in A Parkinson’s Disease Model;International Journal of Molecular Sciences;2024-03-05

3. Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson’s disease;npj Parkinson's Disease;2024-01-06

4. Recent advances in natural products targeting α-synuclein aggregation or clearance in Parkinson's disease;European Journal of Medicinal Chemistry Reports;2023-12

5. Evaluation of ferritin and TfR level in plasma neural-derived exosomes as potential markers of Parkinson’s disease;Frontiers in Aging Neuroscience;2023-09-19